Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN953556 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Myosin Binding Protein C, Cardiac (MYBPC3) (AA 188-218), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Purified through a Protein A column followed by peptide affinity purification
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 188-218, N-Term
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Identification of a novel MYBPC3 gene variant in a patient with hypertrophic cardiomyopathy.
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
A novel custom resequencing array for dilated cardiomyopathy.
Development of a high resolution melting method for the detection of genetic variations in hypertrophic cardiomyopathy.
Brion M, Allegue C, Gil R, Blanco-Verea A, Carracedo A, Pagannone E, Evangelista A, Di Castro S, Marchitti S, Stanzione R, Volpe M, Rubattu S
Annals of clinical and laboratory science 2010 Summer;40(3):285-9
Annals of clinical and laboratory science 2010 Summer;40(3):285-9
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.
Millat G, Bouvagnet P, Chevalier P, Dauphin C, Jouk PS, Da Costa A, Prieur F, Bresson JL, Faivre L, Eicher JC, Chassaing N, Crehalet H, Porcher R, Rodriguez-Lafrasse C, Rousson R
European journal of medical genetics 2010 Sep-Oct;53(5):261-7
European journal of medical genetics 2010 Sep-Oct;53(5):261-7
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
A novel custom resequencing array for dilated cardiomyopathy.
Zimmerman RS, Cox S, Lakdawala NK, Cirino A, Mancini-DiNardo D, Clark E, Leon A, Duffy E, White E, Baxter S, Alaamery M, Farwell L, Weiss S, Seidman CE, Seidman JG, Ho CY, Rehm HL, Funke BH
Genetics in medicine : official journal of the American College of Medical Genetics 2010 May;12(5):268-78
Genetics in medicine : official journal of the American College of Medical Genetics 2010 May;12(5):268-78
Development of a high resolution melting method for the detection of genetic variations in hypertrophic cardiomyopathy.
Millat G, Chanavat V, Créhalet H, Rousson R
Clinica chimica acta; international journal of clinical chemistry 2010 Dec 14;411(23-24):1983-91
Clinica chimica acta; international journal of clinical chemistry 2010 Dec 14;411(23-24):1983-91
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
